Sign in

CIK 0001585608

  • Non-accelerated filer
  • Smaller reporting company

Jaguar Health, Inc.

Sign in to watch
Ticker
JAGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 415-371-8300
Business address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
Former names
Jaguar Animal Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-24 Siegel Jonathan B. Director Grant or award · Warrant to Purchase Common Stock +18,262 9,000
2025-06-24 MICEK JOHN Director Returned to the company · Convertible Promissory Note −9,000 $50,000.00 $450.0M 0
2025-06-24 MICEK JOHN Director Grant or award · Convertible Promissory Note +9,462 $50,000.00 $473.1M 9,462
2025-06-24 MICEK JOHN Director Grant or award · Warrant to Purchase Common Stock +18,262 9,000
2025-06-24 BOCHNOWSKI JAMES J Director Returned to the company · Convertible Promissory Note −27,002 $150,000.00 $4.1B 0
2025-06-24 BOCHNOWSKI JAMES J Director Grant or award · Convertible Promissory Note +28,388 $150,000.00 $4.3B 28,388
2025-06-24 BOCHNOWSKI JAMES J Director Grant or award · Warrant to Purchase Common Stock +54,786 27,002
2025-06-24 King Steven R. See Remarks Returned to the company · Convertible Promissory Note −3,600 $20,000.00 $72.0M 0
2025-06-24 King Steven R. See Remarks Grant or award · Convertible Promissory Note +3,785 $20.00 $76K 3,785
2025-06-24 King Steven R. See Remarks Grant or award · Warrant to Purchase Common Stock +7,304 3,600
2025-06-24 Chaturvedi Pravin R Chief Scientific Officer Returned to the company · Convertible Promissory Note −3,600 $20,000.00 $72.0M 0
2025-06-24 Chaturvedi Pravin R Chief Scientific Officer Grant or award · Convertible Promissory Note +3,785 $20,000.00 $75.7M 3,785
2025-06-24 Chaturvedi Pravin R Chief Scientific Officer Grant or award · Warrant to Purchase Common Stock +7,304 3,600
2025-06-24 Wolin Jonathan S. See Remarks Returned to the company · Convertible Promissory Note −9,000 $50,000.00 $450.0M 0
2025-06-24 Wolin Jonathan S. See Remarks Grant or award · Convertible Promissory Note +9,462 $50,000.00 $473.1M 9,462
2025-06-24 Wolin Jonathan S. See Remarks Grant or award · Warrant to Purchase Common Stock +18,262 9,000
2025-06-24 CONTE LISA A CEO and President Returned to the company · Convertible Promissory Note −9,000 $50,000.00 $450.0M 0
2025-06-24 CONTE LISA A CEO and President Grant or award · Convertible Promissory Note +9,462 $50,000.00 $473.1M 9,462
2025-06-24 CONTE LISA A CEO and President Grant or award · Warrant to Purchase Common Stock +18,262 9,000
2025-05-17 King Steven R. See Remarks Option exercise +1 145

Page 2 of 10 · 185 trades